Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe

BACKGROUND: We examined the feasibility of assessing and referring adults successfully completing TB treatment for comorbidities, risk determinants and disability in health facilities in Kenya, Uganda, Zambia and Zimbabwe. METHODS: This was a cross-sectional study within national TB programmes. RESU...

Full description

Saved in:
Bibliographic Details
Main Authors: The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):, S.A. Adakun, F.M. Banda, A. Bloom, M. Bochnowicz, J. Chakaya, A. Chansa, H. Chiguvare, R. Chimzizi, C. Colvin, J.P. Dongo, A. Durena, C. Duri, R. Edmund, A.D. Harries, I. Kathure, F.N. Kavenga, Y. Lin, H. Luzze, I. Mbithi, M. Mputu, A. Mubanga, D. Nair, M. Ngwenya, B. Okotu, P. Owiti, A. Owuor, P. Thekkur, C. Timire, S. Turyahabwe, E. Tweyongyere, M. YaDiul, R. Zachariah, K. Zimba
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-05-01
Series:IJTLD Open
Subjects:
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000005/art00002
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592279717543936
author The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):
S.A. Adakun
F.M. Banda
A. Bloom
M. Bochnowicz
J. Chakaya
A. Chansa
H. Chiguvare
R. Chimzizi
C. Colvin
J.P. Dongo
A. Durena
C. Duri
R. Edmund
A.D. Harries
I. Kathure
F.N. Kavenga
Y. Lin
H. Luzze
I. Mbithi
M. Mputu
A. Mubanga
D. Nair
M. Ngwenya
B. Okotu
P. Owiti
A. Owuor
P. Thekkur
C. Timire
S. Turyahabwe
E. Tweyongyere
M. YaDiul
R. Zachariah
K. Zimba
author_facet The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):
S.A. Adakun
F.M. Banda
A. Bloom
M. Bochnowicz
J. Chakaya
A. Chansa
H. Chiguvare
R. Chimzizi
C. Colvin
J.P. Dongo
A. Durena
C. Duri
R. Edmund
A.D. Harries
I. Kathure
F.N. Kavenga
Y. Lin
H. Luzze
I. Mbithi
M. Mputu
A. Mubanga
D. Nair
M. Ngwenya
B. Okotu
P. Owiti
A. Owuor
P. Thekkur
C. Timire
S. Turyahabwe
E. Tweyongyere
M. YaDiul
R. Zachariah
K. Zimba
author_sort The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):
collection DOAJ
description BACKGROUND: We examined the feasibility of assessing and referring adults successfully completing TB treatment for comorbidities, risk determinants and disability in health facilities in Kenya, Uganda, Zambia and Zimbabwe. METHODS: This was a cross-sectional study within national TB programmes. RESULTS: Health workers assessed 1,063 patients (78% of eligible) in a median of 22 min [IQR 16–35] and found it useful and feasible to accomplish in addition to other responsibilities. For comorbidities, 476 (44%) had HIV co-infection, 172 (16%) had high blood pressure (newly detected in 124), 43 (4%) had mental health disorders (newly detected in 33) and 36 (3%) had diabetes mellitus. The most common risk determinants were ‘probable alcohol dependence’ (15%) and malnutrition (14%). Disability, defined as walking <400 m in 6 min, was found in 151/882 (17%). Overall, 763 (72%) patients had at least one comorbidity, risk determinant and/or disability. At least two-thirds of eligible patients were referred for care, although 80% of those with disability needed referral outside their original health facility. CONCLUSIONS: Seven in 10 patients completing TB treatment had at least one comorbidity, risk determinant and/or disability. This emphasises the need for offering early patient-centred care, including pulmonary rehabilitation, to improve quality of life, reduce TB recurrence and increase long-term survival.
format Article
id doaj-art-4578425c341f400e87a427a943027262
institution Kabale University
issn 3005-7590
language English
publishDate 2024-05-01
publisher International Union Against Tuberculosis and Lung Disease (The Union)
record_format Article
series IJTLD Open
spelling doaj-art-4578425c341f400e87a427a9430272622025-01-21T10:40:46ZengInternational Union Against Tuberculosis and Lung Disease (The Union)IJTLD Open3005-75902024-05-011519720510.5588/ijtldopen.24.00822Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and ZimbabweThe Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):S.A. Adakun0F.M. Banda1A. Bloom2M. Bochnowicz3J. Chakaya4A. Chansa5H. Chiguvare6R. Chimzizi7C. Colvin8J.P. Dongo9A. Durena10C. Duri11R. Edmund12A.D. Harries13I. Kathure14F.N. Kavenga15Y. Lin16H. Luzze17I. Mbithi18M. Mputu19A. Mubanga20D. Nair21M. Ngwenya22B. Okotu23P. Owiti24A. Owuor25P. Thekkur26C. Timire27S. Turyahabwe28E. Tweyongyere29M. YaDiul30R. Zachariah31K. Zimba32Mulago National Referral Hospital, Kampala, Uganda;University Teaching Hospital, Ministry of Health, Lusaka, Zambia;Credence, Contractor for USAID Health Training, Advisory, and Support Contract (GHTASC), Washington DC, USA;Credence, Contractor for USAID Health Training, Advisory, and Support Contract (GHTASC), Washington DC, USA;Department of Medicine, Therapeutics, Dermatology and Psychiatry Kenyatta University, Nairobi,Ndola Teaching Hospital, Ministry of Health, Ndola, Zambia;United States Agency for International Development (USAID), Harare, Zimbabwe;Ministry of Health, USAID Long-term Exceptional Technical Assistance Project, Genesis, Lusaka, Zambia;United States Agency for International Development (USAID), Harare, Zimbabwe;International Union Against Tuberculosis and Lung Disease (The Union) Uganda Office, Kampala, Uganda;United States Agency for International Development (USAID), Harare, Zimbabwe;Directorate of Health Services, Harare City Council, Harare, Zimbabwe;United States Agency for International Development (USAID), Harare, Zimbabwe;The Union, Paris, France;Ministry of Health, Division of National TB, Leprosy and Lung Disease Programme, Nairobi, Kenya;Ministry of Health and Child Care, AIDS and TB Department, Harare, Zimbabwe;The Union, Paris, France;National Tuberculosis and Leprosy Programme, Ministry of Health, Kampala, Uganda;Respiratory Society of Kenya, Nairobi, Kenya;National Tuberculosis Programme, Ministry of Health/USAID TBLON, Lusaka; Zambia;National Tuberculosis Programme, Ministry of Health/USAID TBLON, Lusaka; Zambia;The Union, Paris, France;Ministry of Health and Child Care, AIDS and TB Department, Harare, Zimbabwe;Ministry of Health, Division of National TB, Leprosy and Lung Disease Programme, Nairobi, Kenya;USAID, Health, Population and Nutrition Office, Kenya and East Africa, Nairobi,Kenyatta National Hospital, Nairobi, Kenya;The Union, Paris, France;The Union, Paris, France;National Tuberculosis and Leprosy Programme, Ministry of Health, Kampala, Uganda;National Tuberculosis and Leprosy Programme, Ministry of Health, Kampala, Uganda;USAID, Washington DC, USA;UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland;USAID, Lusaka, ZambiaBACKGROUND: We examined the feasibility of assessing and referring adults successfully completing TB treatment for comorbidities, risk determinants and disability in health facilities in Kenya, Uganda, Zambia and Zimbabwe. METHODS: This was a cross-sectional study within national TB programmes. RESULTS: Health workers assessed 1,063 patients (78% of eligible) in a median of 22 min [IQR 16–35] and found it useful and feasible to accomplish in addition to other responsibilities. For comorbidities, 476 (44%) had HIV co-infection, 172 (16%) had high blood pressure (newly detected in 124), 43 (4%) had mental health disorders (newly detected in 33) and 36 (3%) had diabetes mellitus. The most common risk determinants were ‘probable alcohol dependence’ (15%) and malnutrition (14%). Disability, defined as walking <400 m in 6 min, was found in 151/882 (17%). Overall, 763 (72%) patients had at least one comorbidity, risk determinant and/or disability. At least two-thirds of eligible patients were referred for care, although 80% of those with disability needed referral outside their original health facility. CONCLUSIONS: Seven in 10 patients completing TB treatment had at least one comorbidity, risk determinant and/or disability. This emphasises the need for offering early patient-centred care, including pulmonary rehabilitation, to improve quality of life, reduce TB recurrence and increase long-term survival.https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000005/art00002tb-associated disabilitytb-associated lung diseasereal-time operational researchsort ituniversal health coverage
spellingShingle The Kenya, Uganda, Zambia, and Zimbabwe TB Disability Study Group (members listed here in alphabetical order):
S.A. Adakun
F.M. Banda
A. Bloom
M. Bochnowicz
J. Chakaya
A. Chansa
H. Chiguvare
R. Chimzizi
C. Colvin
J.P. Dongo
A. Durena
C. Duri
R. Edmund
A.D. Harries
I. Kathure
F.N. Kavenga
Y. Lin
H. Luzze
I. Mbithi
M. Mputu
A. Mubanga
D. Nair
M. Ngwenya
B. Okotu
P. Owiti
A. Owuor
P. Thekkur
C. Timire
S. Turyahabwe
E. Tweyongyere
M. YaDiul
R. Zachariah
K. Zimba
Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
IJTLD Open
tb-associated disability
tb-associated lung disease
real-time operational research
sort it
universal health coverage
title Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
title_full Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
title_fullStr Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
title_full_unstemmed Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
title_short Disability, comorbidities and risk determinants at end of TB treatment in Kenya, Uganda, Zambia and Zimbabwe
title_sort disability comorbidities and risk determinants at end of tb treatment in kenya uganda zambia and zimbabwe
topic tb-associated disability
tb-associated lung disease
real-time operational research
sort it
universal health coverage
url https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000005/art00002
work_keys_str_mv AT thekenyaugandazambiaandzimbabwetbdisabilitystudygroupmemberslistedhereinalphabeticalorder disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT saadakun disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT fmbanda disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT abloom disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT mbochnowicz disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT jchakaya disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT achansa disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT hchiguvare disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT rchimzizi disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT ccolvin disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT jpdongo disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT adurena disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT cduri disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT redmund disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT adharries disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT ikathure disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT fnkavenga disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT ylin disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT hluzze disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT imbithi disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT mmputu disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT amubanga disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT dnair disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT mngwenya disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT bokotu disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT powiti disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT aowuor disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT pthekkur disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT ctimire disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT sturyahabwe disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT etweyongyere disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT myadiul disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT rzachariah disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe
AT kzimba disabilitycomorbiditiesandriskdeterminantsatendoftbtreatmentinkenyaugandazambiaandzimbabwe